10X Genomics Inc is a biotechnology company focused on advancing the field of genomics through innovative technologies that enable researchers to explore biological systems at a single-cell level. The company's mission is to empower scientists to unlock the complexities of biology and disease by providing high-resolution genomic analysis tools. 10X Genomics Inc employs a strategy centered on continuous innovation and collaboration with the scientific community, offering a range of products that enhance genomic sequencing, gene expression analysis, and spatial biology. Their operations are driven by a commitment to improving human health through groundbreaking research and discoveries in genomics.

10X GENOMICS INC

10x Genomics has recently been under pressure following a 13% to 15% drop in stock price, triggered by the National Institutes of Health (NIH) announcing a cap on indirect expenses related to medical research grants. With over 60% of 10x Genomics' customers reliant on NIH funding, these changes pose significant...

10x Genomics Faces Stock Volatility Amid NIH Funding Cap Announcement, While Ark Invest Boosts Its Stake in the Company

As 10x Genomics grapples with stock volatility following NIH's funding cap announcement, the implications for biomedical research are profound. Can the backing from Ark Invest signal a brighter future amid these challenges?